Analogic Signs Agreement to Acquire Ultrasonix Medical Corporation, Supplier of Advanced Ultrasound Solutions

Analogic Signs Agreement to Acquire Ultrasonix Medical Corporation, Supplier
of Advanced Ultrasound Solutions

Accelerates Penetration Into Fast Growing Point-of-Care Market

PEABODY, Mass., Jan. 8, 2013 (GLOBE NEWSWIRE) -- Analogic Corporation
(Nasdaq:ALOG), enabling the world's medical imaging and aviation security
technology, announced today that it has signed an agreement to acquire
privately held Ultrasonix Medical Corporation based in Vancouver, Canada for
$83 million in cash. Ultrasonix is a supplier of advanced ultrasound systems
for point-of-care and general imaging applications with over 5,000 systems
installed worldwide. The purchase price paid to Ultrasonix shareholders will
be funded out of Analogic's available cash balance. The transaction is
expected to close in late February. Analogic expects that this business
combination will be neutral to EPS in Analogic's fiscal year 2013, excluding
purchase accounting adjustments and transaction related costs, but will become
accretive in fiscal year 2014. Further information on this transaction can be
found on supplemental presentation slides by clicking here or at
http://investor.analogic.com.

Jim Green, Analogic president and CEO, commented, "Ultrasonix brings key
ultrasound technology and a direct distribution channel, complementary to our
own. This acquisition is an important step in executing our overall growth
strategy as we expand our direct ultrasound business into the fast growing
adjacent point-of-care ultrasound market. Ultrasonix also enables expanded
distribution into general imaging in emerging markets with advanced technology
to address diagnostic procedures and applications. This acquisition provides
significant revenue and operational synergies as well as provides scale to our
existing ultrasound business accelerating our growth in the future."

Green added, "In addition to all that Ultrasonix brings to us, Analogic brings
advanced technical prowess and expanded sales channel access to the Ultrasonix
portfolio."

The transaction brings together BK Medical and Ultrasonix, two of the world's
leading producers of mobile, procedure-driven, guided ultrasound technology.
Founded in 2000, Ultrasonix has a broad portfolio of mobile ultrasound
products with an established brand used primarily for point-of-care
applications such as emergency medicine and anesthesia in developed markets
and general imaging in emerging markets. Ultrasonix's audited revenue for the
calendar year ended December 31, 2011 was 34.5 million Canadian dollars, with
positive operating income.

Excluding the Ultrasonix acquisition, the Company confirmed its outlook for FY
2013, expecting upper single-digit organic revenue growth with 100 basis
points operating margin improvement over fiscal 2012.

Upcoming Investor Conferences

Analogic management will be presenting at two upcoming webcasted investor
conferences in January to discuss Analogic's strategy and elaborate further on
the acquisition of Ultrasonix. Jim Green will speak at the J.P. Morgan
Healthcare Conference on Thursday, January 10, at the Westin Saint Francis
Hotel in San Francisco. The 25-minute presentation and 25-minute Q&A session
are scheduled to begin at 10:30 a.m. PST. Jim will also speak at the Needham
Growth Conference on Tuesday, January 15, at the New York Palace Hotel in New
York City. The 20-minute presentation and 20-minute Q&A session are scheduled
to begin at 2:50 p.m. ET. Both the J.P. Morgan and Needham conference
presentations will be webcast live and can be accessed via our website at
http://investor.analogic.com. 

Forward-Looking Statements

Any statements about future expectations, plans, and prospects for the
Company, including statements containing the words " believes," "
anticipates," " plans," " expects," and similar expressions, constitute
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. Actual results may differ materially from those
indicated by such forward-looking statements as a result of various important
factors, including risks relating to product development and
commercialization, limited demand for the Company's products, risks associated
with competition, uncertainties associated with regulatory agency approvals,
competitive pricing pressures, downturns in the economy, the risk of potential
intellectual property litigation, and other factors discussed in our most
recent quarterly report filed with the Securities and Exchange Commission. In
addition, the forward-looking statements included in this presentation
represent the Company's views as of the date of this document. While the
Company anticipates that subsequent events and developments will cause the
Company's views to change, the Company specifically disclaims any obligation
to update these forward-looking statements. These forward-looking statements
should not be relied upon as representing the Company's views as of any later
date.

About Analogic 

Analogic (Nasdaq:ALOG) provides leading-edge healthcare and security
technology solutions to advance the practice of medicine and save lives. We
are recognized around the world for advanced imaging systems and technology
that enable computed tomography, ultrasound, digital mammography, and magnetic
resonance imaging (MRI), as well as automated threat detection for aviation
security. Our CT, MRI, digital mammography, and ultrasound transducer products
are sold to original equipment manufacturers (OEMs), providing
state-of-the-art capability and enabling them to enter new markets and expand
their existing market presence. Our market-leading BK Medical branded
ultrasound systems, used in procedure-driven markets such as urology, surgery,
and anesthesia, are sold to clinical end users through our direct sales force.
For over 40 years we've enabled customers to thrive, improving the health and
enhancing the safety of people around the world. Analogic is headquartered
just north of Boston, Massachusetts. For more information, visit
www.analogic.com.

About Ultrasonix

Ultrasonix develops and manufactures diagnostic ultrasound imaging systems
designed to make ultrasound easy to use in more areas of patient care. The
company's customizable systems are built on an open software platform that
enables remote service and easy updates to keep current with advancements in
imaging technology. Founded in 2000, Ultrasonix is headquartered in Richmond,
British Columbia, Canada. www.ultrasonix.com.

Analogic is a registered trademark of Analogic Corporation.

The globe logo is a trademark of Analogic Corporation.

CONTACT: Investor Contact:
         Mark Namaroff
         Director of Investor Relations
         (978) 326-4058
         investorrelations@analogic.com
        
         Media Contact:
         Lars Shaw
         Vice President of Global Marketing
         (408) 605-3901
         lshaw@analogic.com

Analogic Logo
 
Press spacebar to pause and continue. Press esc to stop.